Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,269 | 652 | 88.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $800.00 | 1 | 5.8% |
| Consulting Fee | $500.00 | 1 | 3.6% |
| Education | $269.53 | 5 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $1,851 | 67 | $0 (2024) |
| LEO Pharma Inc. | $1,665 | 68 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,513 | 58 | $0 (2024) |
| ABBVIE INC. | $1,434 | 77 | $0 (2024) |
| Janssen Biotech, Inc. | $1,219 | 74 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $819.56 | 37 | $0 (2024) |
| PFIZER INC. | $776.75 | 47 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $634.98 | 30 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $632.22 | 50 | $0 (2024) |
| Journey Medical Corporation | $587.49 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,659 | 183 | Incyte Corporation ($1,297) |
| 2023 | $3,546 | 186 | LEO Pharma Inc. ($598.89) |
| 2022 | $3,024 | 166 | ABBVIE INC. ($487.60) |
| 2021 | $2,609 | 124 | Journey Medical Corporation ($500.00) |
All Payment Transactions
659 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $9.44 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Podiatry | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Incyte Corporation | OPZELURA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Inflammation | ||||||
| 12/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $9.04 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.04 | General |
| 11/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Immunology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.20 | General |
| Category: Immunology | ||||||
| 11/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.97 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 359 | 593 | $49,069 | $11,170 |
| 2022 | 14 | 948 | 1,613 | $143,768 | $46,937 |
| 2021 | 13 | 818 | 1,444 | $124,516 | $43,611 |
| 2020 | 8 | 311 | 467 | $43,359 | $15,747 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $10,010 | $2,561 | 25.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 48 | 49 | $7,394 | $2,250 | 30.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 81 | 84 | $10,531 | $1,712 | 16.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 38 | 39 | $7,012 | $1,551 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 57 | $7,805 | $1,444 | 18.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 60 | 288 | $3,842 | $1,022 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 17 | $2,476 | $629.64 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 214 | $29,318 | $10,015 | 34.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 113 | 124 | $18,104 | $7,483 | 41.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 173 | 200 | $26,400 | $5,059 | 19.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 86 | 86 | $14,792 | $4,818 | 32.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 26 | 34 | $6,936 | $3,435 | 49.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 66 | 70 | $12,825 | $3,411 | 26.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 142 | 702 | $9,828 | $2,823 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 45 | $6,435 | $2,639 | 41.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 15 | 17 | $3,910 | $1,913 | 48.9% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 23 | 29 | $5,828 | $1,797 | 30.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 39 | 43 | $2,623 | $1,398 | 53.3% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2022 | 13 | 13 | $2,520 | $795.37 | 31.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 17 | 23 | $1,940 | $692.08 | 35.7% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2022 | 12 | 13 | $2,309 | $659.62 | 28.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 169 | 216 | $29,592 | $10,501 | 35.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 90 | 101 | $14,746 | $6,425 | 43.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 96 | 102 | $16,830 | $5,602 | 33.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 145 | 186 | $24,552 | $5,299 | 21.6% |
About Ty Nielson
Ty Nielson is a Medical healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2015. The National Provider Identifier (NPI) number assigned to this provider is 1871988980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ty Nielson has received a total of $13,838 in payments from pharmaceutical and medical device companies, with $4,659 received in 2024. These payments were reported across 659 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($12,269).
As a Medicare-enrolled provider, Nielson has provided services to 2,436 Medicare beneficiaries, totaling 4,117 services with total Medicare billing of $117,465. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Phoenix, AZ
- Active Since 04/06/2015
- Last Updated 08/21/2017
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1871988980
Products in Payments
- OPZELURA (Drug) $1,851
- DUPIXENT (Biological) $1,714
- ADBRY (Biological) $1,420
- TREMFYA (Drug) $920.39
- SKYRIZI (Biological) $870.67
- EUCRISA (Drug) $721.19
- Sotyktu (Drug) $500.93
- JUBLIA (Drug) $403.72
- COSENTYX (Drug) $382.20
- RINVOQ (Biological) $368.67
- COSENTYX (Biological) $344.40
- Ilumya (Biological) $317.11
- REMICADE (Biological) $298.65
- TALTZ (Drug) $290.68
- VTAMA (Drug) $198.15
- OLUMIANT (Drug) $179.33
- HUMIRA (Biological) $172.17
- Cimzia (Drug) $162.40
- ENSTILAR (Drug) $155.82
- ZILXI (Drug) $123.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Phoenix
Thanes Vanig, Md, MD
Medical — Payments: $462,751
Scott Young, Pa, PA
Medical — Payments: $55,738
Jennifer Kiser, Pac, PAC
Medical — Payments: $46,703
Lakeisha Colter, Pa-C, PA-C
Medical — Payments: $24,645
Ms. Brittany Silverman, Pa, PA
Medical — Payments: $12,882
John Rimer, Pa-C, PA-C
Medical — Payments: $11,846